Find Us

Sanofi says we're 'as ready as can be' for Brexit

Sanofi says we're 'as ready as can be' for Brexit
FILE PHOTO: The logo of Sanofi is pictured during the Viva Tech start-up and technology summit in Paris, France, May 25, 2018. REUTERS/Charles Platiau Copyright CHARLES PLATIAU(Reuters)
Copyright CHARLES PLATIAU(Reuters)
By Reuters
Published on Updated
Share this articleComments
Share this articleClose Button

PARIS (Reuters) - Sanofi has nearly completed its preparations for Britain's planned exit from the European Union and is confident its additional stockpiling of medicines and other measures will prevent shortages for patients in the country.

"We have final bits of execution left but our stocks will reach their target levels by the end of February," Hugo Fry, the French drugmaker's chairman for the UK and Ireland told Reuters, adding the company was "as ready as can be."

Fry said Sanofi would stockpile an average of 16 weeks worth of supply across its portfolio, which encompasses products ranging from vaccines to insulin.

(Reporting by Matthias Blamont; Editing by Richard Lough)

Share this articleComments

You might also like